SciSparc Ltd. SPRC 深 滬
已收盤 07-31 16:00:00 美东时间
7.12
-1.580
-18.16%
華盛通- 最 高8.00
- 今 開7.57
- 成交量 10.93万股
- 最 低 6.61
- 昨 收 8.70
- 總市值 408.15万
- 52周最高 80.10
- 市盈率 靜 --
- 換手率 19.07%
- 52周最低 2.98
- 委 比 -83.33%
- 總股本 57.32万
- 歷史最高 34791.12
- 量 比 0.06
- 振 幅 15.98%
- 歷史最低 4.1589
- 每 手 1
- 風險率 14.44%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Going On With SciSparc Shares On Friday?
SciSparc Ltd. (NASDAQ:SPRC) shares are down more than 20% on Friday. On Wednesday, the company disclosed advancements in its quantum platform for clinical data analytics. This news comes amid a generally positive tone in the broader market, with S&P 500 futures gaining about 0.4%. • SciSparc shares ...
07-31 22:22
SciSparc's NeuroThera Labs Subsidiary Completes Internal Validation Of Quantum Sampling Workflow Developed Platform For Clinical Trials Data Analysis
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, has successfully completed internal validation of a propri...
07-29 20:36
SciSparc’s subsidiary NeuroThera Labs Initiates Phase IIb Clinical Trial Site At Hannover Medical School In Germany For SCI-110, Proprietary Cannabinoid-Based Treatment Candidate For Tourette Syndrome In Adults
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that its subsidiary NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, announced the initiation of its Phase IIb c...
07-15 21:00
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers PRF Technologies (NASDAQ:PRFX) stock rose 231.0% to $4.54 during Frida...
05-30 01:06
Why Is SciSparc Stock Skyrocketing On Thursday?
Discover why SciSparc Ltd. (NASDAQ: SPRC) stock is surging today after subsidiary NeuroThera Labs receives TSX approval for a key majority stake acquisition.
05-29 00:28
SciSparc shares are trading higher after the company announced its subsidiary NeuroThera Labs received conditional TSX approval for the acquisition of approximately 54% of interest in CliniQuantum.
SciSparc shares are trading higher after the company announced its subsidiary N...
05-28 21:20
SciSparc Regains Conditional Nasdaq Compliance After Equity Shortfall
SciSparc Ltd. ( ($SPRC) ) just unveiled an update. On January 12, 2026, SciSpar...
05-11 20:29
Why Amazon Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Amazon Inc (NASDAQ: AMZN) rose in pre-market trading after announcing a strategic collaboration with Anthropic to spend $100B on AWS.
04-21 16:43
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares moved upwards by 70.7% to $0.38 during ...
03-13 05:05
Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
Clearmind Medicine Inc. has published an international patent application for a novel combination therapy using MEAI and Palmitoylethanolamide (PEA) to treat obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The therapy targets a growing market valued at $37 billion in 2025 and expected to reach $226 billion by 2035. MEAI-PEA may offer a safer, non-hallucinogenic alternative to GLP-1 agonists, addressing global health ...
03-10 12:59
